20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer.
Looking at options history for Pfizer (NYSE:PFE) we detected 10 strange trades.
If we consider the specifics of each trade, it is accurate to state that 10% of the investors opened trades with bullish expectations and 90% with bearish.
From the overall spotted trades, 3 are puts, for a total amount of $235,125 and 7, calls, for a total amount of $364,884.
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $35.0 to $45.0 for Pfizer over the last 3 months.
Volume & Open Interest Development
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Pfizer's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Pfizer's whale activity within a strike price range from $35.0 to $45.0 in the last 30 days.
Pfizer Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| PFE | PUT | TRADE | NEUTRAL | 11/17/23 | $35.00 | $153.0K | 9.0K | 1.6K |
| PFE | CALL | SWEEP | BEARISH | 03/15/24 | $37.50 | $77.5K | 9.2K | 979 |
| PFE | CALL | TRADE | BEARISH | 03/15/24 | $40.00 | $67.5K | 4.6K | 2.2K |
| PFE | CALL | SWEEP | BEARISH | 03/15/24 | $37.50 | $65.8K | 9.2K | 132 |
| PFE | CALL | SWEEP | NEUTRAL | 12/19/25 | $35.00 | $56.5K | 2.6K | 161 |
Where Is Pfizer Standing Right Now?
- With a volume of 16,792,160, the price of PFE is down -0.69% at $35.9.
- RSI indicators hint that the underlying stock may be approaching overbought.
- Next earnings are expected to be released in 62 days.
What The Experts Say On Pfizer:
- Cantor Fitzgerald downgraded its action to Overweight with a price target of $75
- Morgan Stanley has decided to maintain their Equal-Weight rating on Pfizer, which currently sits at a price target of $40.
- Cantor Fitzgerald downgraded its action to Overweight with a price target of $75
- Truist Securities has decided to maintain their Buy rating on Pfizer, which currently sits at a price target of $62.
- BMO Capital has decided to maintain their Outperform rating on Pfizer, which currently sits at a price target of $44.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Pfizer, Benzinga Pro gives you real-time options trades alerts.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!